Abbott · 21 hours ago
Analyst, Product Surveillance
Abbott is a global healthcare leader that helps people live more fully at all stages of life. They are seeking an Analyst for Product Surveillance to perform various functions within the postmarket surveillance department, including reviewing adverse events and regulatory reporting.
BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical
Responsibilities
May perform multiple functions within the postmarket surveillance department
Major responsibilities would include determining classification, review, and disposition of adverse events and medically related complaints for on-market products, including decisions on seriousness, reportability, and potential causality
Complete FDA MDR and other outside competent authority regulatory reports
Managing complaints from Abbott Field Reps sitting in at procedures/onsite – submitted through complaints system, assignment from the complaint in system
EPIQ complaint handling system
MS Office experience required
Qualification
Required
Four-year degree, preferably in the healthcare or science fields; or 2-year degree and relevant experience supporting complaint handling investigations, medical device reporting, or product analysis
0 - 2 years of experience
MS Office experience required
Preferred
Related experience in post market surveillance in a Medical Device or Pharmaceutical Industry
Lab Experience Nice to Have
Benefits
Medical and Prescription Drug Plans
Dental Plan
Vision Plan
Health Savings Account (for High Deductible Health Plans)
Flexible Spending Accounts (Health, Limited Purpose, Dependent Care, Commuter Parking and Commuter Transit)
Supplemental Life Insurance
Short Term Disability (coverage varies by state)
Long Term Disability
Critical Illness, Hospital coverage, Accident Insurance
MetLife Legal, MetLife ID Fraud, and MetLife Pet Insurance
401(k)
Company
Abbott
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Funding
Current Stage
Public CompanyTotal Funding
$6.79M2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO
Recent News
2026-01-07
Company data provided by crunchbase